Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 27, 2019
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosisMonica Margoni, Francesca Rinaldi, Silvia Miante, et al.
Journal of Neurology|September 29, 2019
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumabMonica Margoni, Francesca Rinaldi, Alice Riccardi, et al.
Cerebellum (London, England)|January 4, 2020
Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple SclerosisAndrea Lazzarotto, Monica Margoni, Silvia Franciotta, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imagingMonica Margoni, Umberto Villani, Erica Silvestri, et al.
Journal of Neurology|March 7, 2020
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onsetMonica Margoni, Silvia Franciotta, Davide Poggiali, et al.
Frontiers in Immunology|June 6, 2022
Hyper-Reflecting Foci in Multiple Sclerosis Retina Associate With Macrophage/Microglia-Derived Cytokines in Cerebrospinal FluidMarco Puthenparampil, Tommaso Torresin, Silvia Franciotta, et al.
Human Brain Mapping|October 13, 2020
Early red nucleus atrophy in relapse-onset multiple sclerosisMonica Margoni, Davide Poggiali, Sofia Zywicki, et al.
Multiple Sclerosis and Related Disorders|July 16, 2023
Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosisSilvia Miante, Monica Margoni, Manuela Moretto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 23, 2022
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple SclerosisMarta Pengo, Silvia Miante, Silvia Franciotta, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
Pageof 1